Cargando…
Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study
BACKGROUND: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity. OBJE...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universidad del Valle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054707/ https://www.ncbi.nlm.nih.gov/pubmed/33911320 http://dx.doi.org/10.25100/cm.v52i1.4542 |